Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Rznomics

Biotech & Life Sciences · Yongin-si, South Korea · Founded 2017 Unicorn

Developing RNA-based gene therapies targeting cancer and rare diseases

Valuation
$1.99B
Market cap · May/2026
Revenue
$6.6M
Latest reported FY

Investors

10 investors on Rznomics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage
IBK Capital
Aon
UTC Investment
Korea Development Bank
Shinhan Venture Investment
Synergy IB Investment
SBI Investment Korea
Partners Investment
QUAD Ventures
LSK Investment

Global footprint

Where Rznomics has talent and traffic

Workforce by country
2 countries with
team presence
🇰🇷 South Korea87.2%
🇬🇧 United Kingdom12.8%
2 countries shown
Web traffic by country
25K monthly visits
across markets
🏳️ Korea96%
🏳️ Republic of2%
🇺🇸 United States0%
Top 3 markets shown

Patent intelligence

$6M patent portfolio · 24 active families

Estimated portfolio value
$6M
0.28% of market cap · 489.4× smaller than top peer Illumina ($2.7B)
24 active patent families
Where Rznomics innovates RibozymeMolecular biologyTrans-splicingRibosomal RNA GenesCancer research

Where Rznomics concentrates vs peers

Each axis is a top-10 topic across Rznomics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Rznomics

An AI-synthesized read of the highest-engagement posts about Rznomics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rznomics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.